Spots Global Cancer Trial Database for Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer
Official Title: A Non-interventional, Multi-centric, Observational, Prospective Study to Collect the Criteria on Which Renewal of GnRH Analogue Treatment With Triptorelin (Diphereline 3.75mg or Diphereline pr 11.25mg) is Made in Patients Recently Diagnosed With Prostate Cancer Requiring Androgen Deprivation Therapy
Study ID: NCT02238366
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to collect some parameters which may help to provide guidance on how Androgen Deprivation Therapy (ADT) drugs are renewed and physician satisfaction.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
, Arad, , Romania
, Bucharest, , Romania
, Cluj-Napoca, , Romania
, Constanta, , Romania
, Craiova, , Romania
, Iasi, , Romania
, Timisoara, , Romania
Contact Details
Name: Ipsen Medical Director
Affiliation: Ipsen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
